Vertex Pharmaceuticals | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 12.48B 1.56B 2025-03
Acadia Pharmaceuticals USD 119.69M 5.97M 2025-06
Agios Pharmaceuticals USD 4.99M 1.64M 2025-06
Alnylam Pharmaceuticals USD 567.11M 149.08M 2025-06
Amgen USD 8.7B 569M 2025-06
Arrowhead Research USD 9.7M 7.33M 2025-06
Biogen USD 2.08B 87.5M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Gilead Sciences USD 4.78B 393M 2025-06
Incyte USD 842.89M 19.76M 2025-06
Insmed USD 55.03M 7.29M 2025-06
Ionis Pharmaceuticals USD 52.58M 12.87M 2025-06
J&J USD 16.02B 1.18B 2025-03
Merck USD 12.72B 1.14B 2025-06
Moderna USD 457M 151M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Novartis USD 9.18B 451M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
PTC Therapeutics USD 196.13M 14.36M 2025-06
Regeneron Pharmaceuticals USD 5.61B 49M 2025-06
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.21B 7.76B 2025-06
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
Ultragenyx Pharmaceutical USD 124.46M 25.62M 2025-06
United Therapeutics USD 379.3M 57.3M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06


Vertex Pharmaceuticals Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.